Equity
€28,705 from €54,506 in 2022
Equity fell by 47% in 2 years.
ROZOW A.
Lifetime
19 annual accounts with figures on one time axis, 23 filings since 2002peak €61,339 (2022)
€57,983▲ 76.7%
lowest -€20,531 (2023)
-€5,271▲ €15,260
peak €54,506 (2022)
€28,705▼ 15.5%
€55,561▼ 27.8%
Board1 name since 2001
1 directorROZOW Avshalom
Documentsfilings and deeds
03-07-202528 days before the deadline
2024micro format
Gross margin from €32,810 to €57,983Loss of €5,271Equity from €33,976 to €28,705Debts from €76,987 to €55,561
Key points
from the 2024 annual accountsChecked score
53
Fair
Financially stronger than 17% of micro companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%
A confirmed filing finding caps the score at 59.
Bankruptcy probability within 12 months
1.3% Low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,180 companies (NACE 86, micro).
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.8%
01-2025: 0.8%● unchanged vs 12-2024
02-2025: 0.8%● unchanged vs 01-2025
03-2025: 0.8%● unchanged vs 02-2025
04-2025: 0.8%● unchanged vs 03-2025
05-2025: 0.8%● unchanged vs 04-2025
06-2025: 0.8%● unchanged vs 05-2025
07-2025: 0.9%▲ +0.1 percentage points vs 06-2025
08-2025: 0.3%▼ -0.6 percentage points vs 07-2025lowest value
09-2025: 0.3%● unchanged vs 08-2025lowest value
10-2025: 0.3%● unchanged vs 09-2025lowest value
11-2025: 0.3%● unchanged vs 10-2025lowest value
12-2025: 0.3%● unchanged vs 11-2025lowest value
01-2026: 0.3%● unchanged vs 12-2025lowest value
02-2026: 0.3%● unchanged vs 01-2026lowest value
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.7%▲ +0.4 percentage points vs 07-2026
09-2026: 0.8%▲ +0.1 percentage points vs 08-2026
10-2026: 1.3%▲ +0.5 percentage points vs 09-2026highest value
11-2026: 1.3%● unchanged vs 10-2026highest value
Financial strengthAverage
Score breakdown
raises risk
Capped at 59: a confirmed filing finding
Figures for financial year 2024 (filed on 08-07-2025)
Liquidity: current ratio 0.19
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €84,266
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 29% of them on solvency, 6% on liquidity, 10% on profitability and 24% on growth.
The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2024.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 12,322 companies had the same profile as ROZOW A. has now. Each dot stands for 31 companies, two years later.
90.3%
were still trading
8.6%
stopped another way
0.7%
went bankrupt
Another 0.5% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of ROZOW A. itself is higher: 1.3% within 12 months. It rests on far more data about ROZOW A. than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 12,322 companies, not a prediction for ROZOW A.. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,500 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity is insufficient, with a current ratio of 0.19 (0.14 in 2023), below 1. Short-term debt is 64.7% of total assets. 65.9% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Eight signals.
lowers riskraises riskneutral
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024Net result per financial year
18192021222324
2018 to 2024 · latest year -€5,271
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 19753 sector peers (2024).
NBB · sector comparisonPosition among 19753 sector peers
Solvency
better than 23%
← weakest
strongest →
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 99 days later.
NBB · 10 filingsPosition against the passed deadline
31-12-2025 year end31-07-2026 deadline07-11-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 03-07-2025, 28 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not filed
2024
28 days early
2023
22 days late
2022
38 days early
2021
38 days late
2020
61 days late
2019
33 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 6 accounts on average 4 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (1)
Recent changes
Reappointment: ROZOW Avshalom (director)
General meeting of 23-11-2023 · Gazette deed
Incorporation
published on 12-05-2001 · Gazette deed
First establishment
Grand-Fond 94, Vielsalm
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ROZOW A. Vielsalm | €84,266 | €57,983 | 34.1% | - |
| MADANI Uccle | €91,595 | €56,688 | 83.6% | - |
| DIDIER EYCKEN Ixelles | €76,238 | €53,655 | 68.0% | - |
| Tandartspraktijk Expodent Essen | €98,103 | €52,766 | 59.7% | 0.5 |
| ECA&R Halle | €106,748 | €57,450 | 68.6% | - |
| CENTRE DENTAIRE LA SANTE Uccle | €109,569 | €61,744 | -127.4% | - |
| BRAMS DENTAL Brussels | €58,951 | €49,242 | 87.7% | - |
These companies have the same main activity as ROZOW A.: dental practice (NACE 86230). They are comparable in size and age: total assets between €59,000 and €110,000, founded between 1994 and 2005.
Official details
Source: KBO- Status
- Active since 30-04-2001Normal situation
- Activity
- Dental practiceNACE 86230
- Establishment unit
- 2.273.612.8906692 Vielsalm, since 30-04-2001
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2024
- ≈ €130,000estimated
- €84,266▼ 24.1%
- Employeeson 31-12-2024
- 1=
- Filing
- Filed on 03-07-2025
Insights on ROZOW A.
ROZOW A. files the micro format. That format states no turnover. The gross margin rose from €13,330 in 2006 to €57,983 in 2024.
The balance sheet grew most from 2020 to 2022 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ROZOW A.
- What is the company number of ROZOW A.?
- The company number of ROZOW A. is 0474.712.456. The VAT number is the same number with BE in front: BE 0474.712.456.
- Where is ROZOW A. based?
- The registered office is at Grand-Fond 94B, 6692 Vielsalm.Company details
- What does ROZOW A. do?
- According to the KBO register, the main activity is dental practice (NACE 86230).
- What is the legal form of ROZOW A.?
- ROZOW A. is a private limited company (BV).
- When was ROZOW A. founded?
- ROZOW A. was founded on 30-04-2001.
- Is ROZOW A. still active?
- Yes, ROZOW A. is an active enterprise in the KBO register.
- How many employees does ROZOW A. have?
- ROZOW A. had an average of 1 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
- What is the turnover of ROZOW A.?
- The turnover in financial year 2024 is ≈ €130,000. This figure is estimated from the gross margin of €57,983 and 32 comparable companies (NACE 862). It probably lies between €100,000 and €170,000.
- Is ROZOW A. profitable?
- In financial year 2024, ROZOW A. made a loss of €5,271.
- Where can I find the annual accounts of ROZOW A.?
- ROZOW A. filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.